📌 Key Takeaways
- Topic: What Is Silica D50? How Median Particle Size Is Measured and Why It Matters
- Keywords: silicon dioxide formula
- Published: 2026-11-20 11:54:33
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is a Silane Coupling Agent? How It Works and How to Choose One for Silica
- Silica as a Moisture Absorber: How It Works and How Much You Need
- 27. Argyo C., Weiss V., Bräuchle C., Bein T. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem. Mater. 2014;26:435-451. doi: 10.1021/cm402592t. [ DOI ] [ Google Scholar ]
- Quartz Sand for Photovoltaic: High Purity Requirements for Solar Crucibles
- 6.1. Targeted Therapy
- Hydrophobic Silica Powder: Properties, Water Repellency and Industrial Uses
- The carriers can have ordered and disordered pore structures [ 1, 2 ]. The ordered mesopores have a regular, homogeneous pore structure and a tunable internal frame, which permits the optimization of the API formulation, while the disordered ones have a random distribution of pore structure. Pores can be divided into two chief groups according to their geometry. There are open and closed pores, based on whether the pore is accessible to the medium or not. In the case of open pores, further differentiation is also possible. Blind pores are only accessible from one direction, while through pores are accessible from at least two directions [ 3 ]. The arrangement of the pores can also be defined and changed, hence the kinetics and dynamics of the release of the API can be influenced and regulated [ 1 ]. Laminar (tubular), radial, hexagonal, or cubic arrangements can also be created [ 1 ]. It is well known that the pore size significantly affects drug loading and drug release [ 1, 3 ]. Nonetheless, the literature is not crystal clear regarding correlation [ 14 ]. Some studies show proof that larger pores provide faster drug release [ 15, 16, 26 ], and larger pores have demonstrated a faster degradation rate in the lymph nodes [ 15 ], and reports limited release for smaller pores as they limit the diffusion process, which is called the steric hindrance influence [ 16, 26 ]. Nevertheless, in other publications, proof recommends that larger pores facilitate slower drug release, as the drug is loaded and trapped in deeper channels, requiring a longer access time for the release medium [ 14 ]. In general, the adsorption capacity can indeed be increased by increasing the specific surface area of the carrier and by decreasing the pore diameter [ 17 ].
- Silica Gel Beads: Types, Sizes, Indicating vs Non-Indicating and Uses
- In spite of the advantages of solvent-free processes, solvent-based techniques offer a more widespread choice for filling the pores of the carriers. Each method listed here consists of two steps. First, mixing the drug solution and carrier, then removing the solvent [ 36 ]. The loading cycles can be repeated as many times as desired to increase the charging efficiency [ 20, 36 ]. These techniques can be effectively applied to molecules both with great and poor aqueous solubility [ 37 ]. However, removing the solvent residue at the end of the process is essential, owing to the toxicity of usually used organic solvents [ 56 ], and it is normally better to select a less toxic organic solvent, if possible [ 37, 56 ]. The adsorption of the API is also influenced by the properties of the solvent, such as viscosity or surface tension. This group includes the adsorption approach, the incipient wetness approach, the solvent evaporation method, and the use of liquid and supercritical CO 2. The adsorption technique (solvent immersion method) is a low-energy process, but the pores can be filled effectively only if the API reaches a high concentration in the solvent [ 37 ]. The carrier system is immersed in the concentrated drug solution, while the liquid fills the pores owing to capillary forces. The mesopores are then separated from the solution by filtration or centrifugation. Finally, the pores are dried under reduced pressure [ 2, 36, 37 ]. Drug loading abilities can be seen for some APIs by this loading approach, in the following figure ( Figure 1 ). During the incipient wetness impregnation, a greatly concentrated drug solution is added dropwise onto the surface of the mesopores, in a nearly equal volume to the pore volume of the carrier [ 37 ]. In this case, the pores are filled with liquid also owing to the capillary forces. Then the pores are dried out at a higher temperature and under reduced pressure [ 2, 36, 37 ]. Nevertheless, the third approach, solvent evaporation, is the most widely used because it can be applied to a wide range of molecules, regardless of their solubility, making it fitting for higher therapeutic doses as well. It is not necessary to prepare a concentrated solution since the concentration gradually increases during the process (owing to the evaporation of the solvent). During the process, the drug should be dissolved in a volatile organic solvent, which is mixed with the carrier system [ 20 ]. All solvents are then eliminated by quick evaporation [ 37 ], while the drug is absorbed into the pores of the drug carrier [ 36, 37 ]. The use of supercritical CO 2 brings about more productive and deeper pore filling compared to other solvents. In this state, neither a liquid phase nor a gas phase exists. It combines the brilliant diffusion capacity of gases and the excellent solvation capacity of liquids. In addition, it is non-toxic, non-flammable, and can be readily eliminated from the system. A cost-effective choice can be liquid CO 2, which is a similarly effective solvent [ 36, 37 ].
What Is E551? Silicon Dioxide as a Food Additive, Uses and Safety
What is silica (SiO₂)?
silica price trend 7. Vallet-Regi M., Rámila A., Del Real R.P., Pérez-Pariente J. A new property of MCM-41: Drug delivery system. Chem. Mater. 2001;13:308-311. doi: 10.1021/cm0011559. [ DOI ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
silica supplier Katalin Kristó
What drives silica raw material prices?
matting agent for coatings Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.